Report cover image

Biologics Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published Oct 06, 2025
Length 571 Pages
SKU # BRC20450889

Description

Biologics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for biologics ? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biologics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider biologics market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug classification, by route of administration, by mode of purchase and by distribution channel.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by drug classification, by route of administration, by mode of purchase and by distribution channel in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for biologics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Type: Monoclonal Antibodies (MABS); Therapeutic Proteins; Vaccines

2) By Drug Classification: Branded Drugs; Generic Drugs

3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration

4) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies Or Drug Stores; Other Distribution Channels

Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Regeneron Pharmaceutical Inc.

Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biologics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

571 Pages
1 Executive Summary
1.1 Biologics – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Biologics Market Definition And Segmentations
6.4 Market Segmentation By Type
6.4.1 Monoclonal Antibodies (MAbS)
6.4.2 Therapeutic Proteins
6.4.3 Vaccines
6.5 Market Segmentation By Drug Classification
6.5.1 Branded Drugs
6.5.2 Generic Drugs
6.6 Market Segmentation By Route Of Administration
6.6.1 Oral
6.6.2 Parenteral
6.6.3 Other Route Of Administration
6.7 Market Segmentation By Mode Of Purchase
6.7.1 Prescription-Based Drugs
6.7.2 Over-The-Counter Drugs
6.8 Market Segmentation By Distribution Channel
6.8.1 Hospital Pharmacies
6.8.2 Retail Pharmacies Or Drug Stores
6.8.3 Other Distribution Channels
7 Major Market Trends
7.1 Enhancing Access To Anti-Angiogenic Therapies Via Biosimilars
7.2 Enhancing Access To Biologic Therapies In Autoimmune Segments
7.3 Supporting Disease Management With Affordable Biologic Solutions
7.4 Advancing High-Concentration Biologic Formulations
7.5 Enhancing Delivery Efficiency In Advanced Therapies
8 Global Biologics Growth Analysis And Strategic Analysis Framework
8.1 Global Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End Users (B2B Market)
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Biopharmaceutical Companies
8.2.4 Contract Research Organizations (CROs)
8.2.5 Home Healthcare Providers
8.2.6 Other End Users
8.3 Global Biologics Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019– 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Global Biologics Total Addressable Market (TAM)
9 Global Biologics Market Segmentation
9.1 Global Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Biologics Market, Sub-Segmentation Of Monoclonal Antibodies (MAbs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
9.7 Global Biologics Market, Sub-Segmentation Of Therapeutic Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
9.8 Global Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
10 Global Biologics Market, Regional and Country Analysis
10.1 Global Biologics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Biologics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia Pacific Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia Pacific Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Biologics Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Investments
11.19.11 Major Companies
11.20 Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Investments
11.33.11 Major Companies
11.34 South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.37 Bangladesh Market
11.38 Bangladesh Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.39 Bangladesh Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.40 Bangladesh Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.41 Thailand Market
11.42 Thailand Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.43 Thailand Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.44 Thailand Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.45 Vietnam Market
11.46 Vietnam Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.47 Vietnam Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.48 Vietnam Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.49 Malaysia Market
11.50 Malaysia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.51 Malaysia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.52 Malaysia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.53 Singapore Market
11.54 Singapore Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.55 Singapore Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.56 Singapore Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.57 Philippines Market
11.58 Philippines Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.59 Philippines Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.60 Philippines Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.61 Hong Kong Market
11.62 Hong Kong Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.63 Hong Kong Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.64 Hong Kong Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.65 New Zealand Market
11.66 New Zealand Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.67 New Zealand Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.68 New Zealand Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate tax structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.8 UK Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.16 France Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.26 Austria Market
12.27 Austria Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.28 Austria Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.29 Austria Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.30 Belgium Market
12.31 Belgium Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.32 Belgium Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.33 Belgium Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.34 Denmark Market
12.35 Denmark Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.36 Denmark Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.37 Denmark Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.38 Finland Market
12.39 Finland Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.40 Finland Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.41 Finland Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.42 Ireland Market
12.43 Ireland Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.44 Ireland Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.45 Ireland Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.46 Netherlands Market
12.47 Netherlands Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.48 Netherlands Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.49 Netherlands Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.50 Norway Market
12.51 Norway Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.52 Norway Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.53 Norway Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.54 Portugal Market
12.55 Portugal Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.56 Portugal Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.57 Portugal Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.58 Sweden Market
12.59 Sweden Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.60 Sweden Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.61 Sweden Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.62 Switzerland Market
12.63 Switzerland Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.64 Switzerland Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.65 Switzerland Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.10 Czech Republic Market
13.11 Czech Republic Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.12 Czech Republic Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.13 Czech Republic Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.14 Poland Market
13.15 Poland Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.16 Poland Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.17 Poland Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.18 Romania Market
13.19 Romania Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.20 Romania Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.21 Romania Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.22 Ukraine Market
13.23 Ukraine Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.24 Ukraine Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.25 Ukraine Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Biologics Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.19 Mexico Market
14.20 Mexico Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.21 Mexico Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.22 Mexico Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 South America Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Biologics Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.11 Chile Market
15.12 Chile Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.13 Chile Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.14 Chile Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.15 Argentina Market
15.16 Argentina Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.17 Argentina Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.18 Argentina Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.19 Colombia Market
15.20 Colombia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.21 Colombia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.22 Colombia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.23 Peru Market
15.24 Peru Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.25 Peru Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.26 Peru Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.6 Middle East Biologics Market: Country Analysis
16.7 Saudi Arabia Market
16.8 Saudi Arabia Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.9 Saudi Arabia Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.10 Saudi Arabia Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.11 Israel Market
16.12 Israel Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.13 Israel Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.14 Israel Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.15 Iran Market
16.16 Iran Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.17 Iran Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.18 Iran Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.19 Turkey Market
16.20 Turkey Biologics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.21 Turkey Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.22 Turkey Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.23 United Arab Emirates (UAE) Market

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us